Microfluidic-electrochemical biosensor for continuously monitoring epilepsy-related non-electroactive neurotransmitter glutamic acid
Through the design of microfluidic-electrochemical biosensors, the continuous monitoring of the epilepsy-related neurotransmitter glutamate is achieved using glutamate dehydrogenase and laser engraving technology, and the diagnosis is time-consuming and expensive in the existing technology. The problem of insufficient detection sensitivity provides low-cost, high-sensitivity detection solutions to support the early diagnosis and personalized treatment of epilepsy.
Patent Information
- Application Number
- CN202411012437.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-12
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing epilepsy diagnosis methods are time-consuming, expensive and low throughput, making it difficult to achieve sensitive detection of the epilepsy-related neurotransmitter glutamate, limiting the early diagnosis and personalized treatment of epilepsy diseases.
Develop a microfluidic-electrochemical biosensor for continuous monitoring of the non-electroactive neurotransmitter glutamate associated with epilepsy, using glutamate dehydrogenase as a neurotransmitter affinity element, combining laser engraving technology and acrylic plates Made a microfluidic device to realize low-cost and low sample consumption detection.
It realizes stable and repeated glutamate detection in biological fluids, with good sensitivity and specificity, and is suitable for glutamate determination in epilepsy cell models, supporting epilepsy disease mechanism research and clinical detection.
Smart Images

Figure CN118937431A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biosensor technology, and more specifically, relates to a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter. The constructed microfluidic-electrochemical biosensor can be used in the fields of epilepsy disease mechanism research and clinical detection, microfluidic chip systems, organoid chip platforms, etc. Background Art
[0002] Epilepsy is a common neurological disease characterized by recurrent epileptic seizures caused by abnormal discharges of brain neurons. About 70 million people suffer from epilepsy worldwide. China is one of the countries with the highest prevalence of epilepsy in the world, with about 9.6 million epilepsy patients and about 400,000 new cases each year, which has placed a heavy burden on my country's public health and medical systems. Brain tissue damage caused by epilepsy can be accompanied by the occurrence of a variety of complications related to neural network diseases, such as depression, anxiety, cognitive impairment, and sleep disorders. [7] and diabetes, etc. Although patients can temporarily control epileptic seizures by taking medication, there is no cure, and about 30% of epileptic seizures are still not effectively controlled, which is called "refractory epilepsy", posing a threat to the life and health of patients and reducing their quality of life. Therefore, timely and accurate detection of epileptic lesions and timely, scientific and rational use of drugs are crucial to preventing epileptic seizures and controlling epileptic behavior. Epilepsy diagnosis is an important clinical challenge, and conventional diagnostic methods include non-invasive electroencephalography, invasive electrocorticography, computed tomography, positron emission tomography, magnetic resonance imaging, and magnetoencephalography. However, these methods are usually time-consuming, expensive, low-throughput, and require high professional skills. Therefore, it is imperative to develop new technologies for epilepsy diagnosis.
[0003] Imbalance in the levels of excitatory and inhibitory neurotransmitters is one of the main causes of epileptic seizures. Glutamate is the main excitatory neurotransmitter in the central nervous system and is essential for maintaining normal brain function. The process of excessive neuronal excitation and death caused by the accumulation of excessive glutamate in synapses and extrasynaptic spaces is called "glutamate excitotoxicity", which is the main cause of epileptic seizures. Astrocytes play an important role in the process of epileptic seizures. One of their key functions is to regulate neurotransmitter homeostasis. They can take up neurotransmitters released by synapses, such as glutamate, to prevent their excessive accumulation in the synaptic cleft. Astrocytes also release glutamate to neighboring neurons to synchronize neuronal discharge, thereby regulating the excitatory or inhibitory activities of the brain's neural network. This dual function makes astrocytes a potential therapeutic target for central nervous system diseases related to glutamate excitotoxicity. Long-term high levels of extracellular glutamate can cause serious damage to nerve cells and even lead to their death. In view of the potential impact of glutamate on epilepsy, the development of new technologies and methods to achieve sensitive detection of the concentration of the neurotransmitter glutamate in the brain and extracellular fluid can provide a strong reference for early clinical diagnosis, disease monitoring and personalized treatment of epilepsy patients.
[0004] In recent years, with the continuous development of detection technology, a variety of emerging detection technologies have been used for the detection of epilepsy-related non-electroactive neurotransmitter glutamate, such as high-performance liquid chromatography, liquid chromatography-mass spectrometry, magnetic resonance spectroscopy, spectrophotometry and capillary electrophoresis. Although these methods have high sensitivity and selectivity, they are limited in their widespread use in practical applications due to the limitations of high equipment cost, complex operation and the need for professional operation. Electrochemical biosensor technology has unique advantages such as low cost, rapid response, simple operation and high sensitivity, providing a new way for the rapid and accurate detection of glutamate. Microfluidic technology, as an emerging technology for operating and analyzing fluids under microscale conditions, can be integrated with low-cost, high-sensitivity and simple-to-operate electrochemical biosensors to give the analysis system the advantages of miniaturization, automation, low sample consumption and low cost, which can make up for the lack of analysis components in microfluidic organ chips and realize real-time electrochemical monitoring of neurotransmitters.
[0005] Therefore, the present invention proposes a microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate. The microfluidic-electrochemical biosensor is prepared by simple commercial materials and alternative technologies, thereby achieving low-cost microfluidic-electrochemical biosensor preparation and repeated detection of glutamate in biological fluids, providing technical support for the detection of epilepsy-related neurotransmitter glutamate and other non-electroactive neurotransmitters. Summary of the invention
[0006] 1. The purpose of the present invention is to provide a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter.
[0007] 2. The microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, described in the present invention uses glutamate dehydrogenase as a neurotransmitter affinity element and uses laser engraving technology to use an acrylic plate as a microfluidic device substrate to manufacture the microfluidic-electrochemical biosensor at a low cost.
[0008] 3. The microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, described in the present invention enables the electrochemical biosensor to stably and repeatedly detect in biological fluids.
[0009] 4. The continuous detection of glutamate in a microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate described in the present invention includes detection in phosphate buffer and cell culture medium.
[0010] 5. The method for making a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, according to the present invention comprises the following steps in sequence:
[0011] (1) After the surface of the screen-printed electrode (SPCE) was cleaned, chitosan (CS) was modified on the electrode surface to prepare a chitosan-modified screen-printed electrode (CS / SPCE);
[0012] (2) Gelatin (GEL) and glutamate dehydrogenase (GLDH) were further modified on the surface of CS / SPCE to prepare glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrodes (GLDH / GEL / CS / SPCE);
[0013] (3) designing and manufacturing a microfluidic device substrate, assembling GLDH / GEL / CS / SPCE with the microfluidic device substrate to manufacture a microfluidic-electrochemical biosensor;
[0014] (4) Detection of the neurotransmitter glutamate in flowing liquid using microfluidic-electrochemical biosensors;
[0015] (5) After the neurotransmitter glutamate detection, the electrode surface of the microfluidic-electrochemical biosensor is cleaned by driving the phosphate buffer via a peristaltic pump, and after cleaning, the step (4) of neurotransmitter glutamate detection is repeated.
[0016] 6. The application of a microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate described in the present invention is to construct an epilepsy cell model using human astroglioma cells (U373 cells) as model cells, and use DMEM / F12 complete culture medium containing 100 mmol / L KCl to stimulate the cells to release the neurotransmitter glutamate. The microfluidic-electrochemical biosensor is used to detect the level of glutamate released by the cells in the epilepsy cell model control group, the control model group and the lamotrigine drug intervention group.
[0017] Specifically, the microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, described in the present invention is characterized in that it is prepared by the following steps: (1) fixing glutamate dehydrogenase on the surface of a screen-printed electrode by chitosan and gelatin cross-linking technology to prepare a glutamate dehydrogenase-modified screen-printed electrode; (2) using acrylic material to make a microfluidic device substrate by precise engraving technology; (3) assembling the glutamate dehydrogenase-modified screen-printed electrode prepared in step (1) with the microfluidic device substrate prepared in step (2) to prepare a microfluidic-electrochemical biosensor; (4) using the prepared microfluidic-electrochemical biosensor to detect the glutamate content in a flowing liquid sample by differential pulse voltammetry; (5) driving the liquid flow by a peristaltic pump to transport the test liquid and the buffer solution to perform glutamate detection and clean the microfluidic-electrochemical biosensor electrodes.
[0018] The microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate is characterized in that the applicable test solution includes a phosphate buffer containing glutamate or a U373 cell contact solution, the glutamate concentration range in the phosphate buffer is 0.1 μmol / L to 100 μmol / L, and the glutamate concentration range in the U373 cell contact solution is 0.5 μmol / L to 100 μmol / L.
[0019] The microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, is characterized in that the entire process of liquid flow, signal detection and electrode cleaning in the microfluidic-electrochemical biosensor is completely controlled by a peristaltic pump and an electrochemical workstation, and the glutamate content in the test liquid can be stably and continuously monitored.
[0020] The method for preparing a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, according to the present invention comprises the following steps in sequence:
[0021] (1) After the surface of the screen-printed electrode SPCE is cleaned, chitosan CS is modified on the surface of the screen-printed electrode to prepare chitosan-modified screen-printed electrode CS / SPCE;
[0022] (2) Further modifying gelatin GEL and glutamate dehydrogenase GLDH on the surface of CS / SPCE to prepare glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode GLDH / GEL / CS / SPCE;
[0023] (3) designing and manufacturing a microfluidic device substrate, assembling GLDH / GEL / CS / SPCE with the microfluidic device substrate to manufacture a microfluidic-electrochemical biosensor;
[0024] (4) Detection of the neurotransmitter glutamate in flowing liquid using microfluidic-electrochemical biosensors;
[0025] (5) After the neurotransmitter glutamate is detected, the electrode surface of the microfluidic-electrochemical biosensor is cleaned by driving the phosphate buffer via a peristaltic pump, and after cleaning, the neurotransmitter glutamate detection step (4) is repeated.
[0026] The detection operation method of the microfluidic-electrochemical biosensor prepared by the preparation method of the microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate is characterized in that it includes the following specific steps:
[0027] (1) Cleaning of screen-printed electrode SPCE: After cleaning the SPCE with ultrapure water for 3 times, blow dry with nitrogen to obtain the cleaned SPCE for later use;
[0028] (2) Preparation of chitosan-modified screen-printed electrode CS / SPCE: 7 μL of 0.5 wt% chitosan solution was dripped onto the surface of the SPCE cleaned in step (1), and the mixture was dried naturally at room temperature to obtain a chitosan-modified screen-printed electrode CS / SPCE.
[0029] (3) Preparation of glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode GLDH / GEL / CS / SPCE: 5 μL of 400 U / mL glutamate dehydrogenase GLDH solution and 5 μL of 20 mg / mL gelatin GEL solution were mixed, and then added dropwise to the surface of CS / SPCE prepared in step (2), and incubated in a refrigerator at 4°C overnight to prepare glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode GLDH / GEL / CS / SPCE;
[0030] (4) Preparation of microfluidic device substrate: Use WPS Office PowerPoint to draw the planar structure of the cover plate and the flow slot of the microfluidic substrate. The flow slot is 5.2 cm long, 2 cm wide and 0.1 cm thick. The flow slot includes a sample inlet for the test liquid, a buffer inlet, a cleaning liquid inlet, a mixing area, a bubble collection area, an electrochemical detection area and a waste liquid outlet. The overall length, width and thickness of the cover are completely consistent with those of the flow slot. The cover includes a sample inlet for the test liquid, a buffer inlet, a cleaning liquid inlet, a bubble collection area and a waste liquid outlet. According to the pattern drawn on the substrate, a laser engraving machine is used to carve out a hollow part on the acrylic plate to make the cover plate and the flow slot. The detection area is a hollow circle with a radius of 0.5 cm, which is slightly larger than the SPCE working area, to obtain the microfluidic device substrate.
[0031] (5) Preparation of microfluidic-electrochemical biosensor: The top surface of the flow channel sheet of the microfluidic device substrate obtained in step (4) is adhered with a 0.2 mm thick PET transparent double-sided tape, and the double-sided tape at the liquid inlet and outlet is hollowed out, and the top surface is adhered to the cover plate, and the GLDH / GEL / CS / SPCE obtained in step (3) is adhered to the detection area of the flow channel sheet, with the GLDH / GEL / CS / SPCE modified interface facing the flow channel sheet, and the bottom surface is sealed with a 2 mm thick flexible strong tape, and the gap is filled with light-curable resin, and light-cured for 120 seconds under LED light to obtain a microfluidic-electrochemical biosensor;
[0032] (6) Connecting the microfluidic-electrochemical biosensor to a peristaltic pump: Connecting a rubber hose to each of the sample inlets and waste liquid outlets of the microfluidic-electrochemical biosensor prepared in step (5), the other end of the rubber hose of the sample inlet being connected to a peristaltic pump, and the other end of the rubber hose of the waste liquid outlet being placed in a waste liquid collection tank;
[0033] (7) Electrochemical detection of microfluidic-electrochemical biosensor during liquid flow: A peristaltic pump was used to mix the glutamate test solution with NAD at a flow rate of 5 μL / min. + The buffer solution was pumped into the microfluidic-electrochemical biosensor from the test solution and the buffer injection port, respectively, and mixed using the microchannel to fill the detection area and remain there for 10 minutes. During this period, glutamate dehydrogenase catalyzed the reduction of glutamate to NAD + NADH was generated, and the neurotransmitter glutamate was detected by differential pulse voltammetry (DPV) using a CHI660E electrochemical workstation, with a detection potential of 0-0.8 V, an amplitude of 0.05 V, a pulse width of 0.1 s, a pulse period of 0.2 s, and the oxidation peak current value was recorded;
[0034] (8) Cleaning of the microfluidic-electrochemical biosensor: After the electrochemical detection of the neurotransmitter glutamate in step (7) is completed, the pumping of the solution in the test solution inlet and the buffer inlet is stopped, the peristaltic pump of the cleaning solution inlet is started, and the phosphate buffer PB is pumped into the microfluidic-electrochemical biosensor through the cleaning solution inlet at a flow rate of 50 μL / min to clean the test area. After cleaning, the pumping of the PB buffer is stopped, and step (7) is repeated to perform the neurotransmitter glutamate detection.
[0035] The invention discloses a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an electroactive neurotransmitter related to epilepsy, and its application is characterized by: measuring glutamate released from cells in an epilepsy cell model group, a control model group, and a drug intervention model group; constructing an epilepsy model using human astroglioma cells (U373 cells) as model cells, and using a 100 mmol / L KCl-free DMEM / F12 complete medium stimulated cells to release the neurotransmitter glutamate, and the level of glutamate released by cells was detected using microfluidic-electrochemical biosensor; the control model group was glutamate released by normal U373 cells, the epilepsy cell model group was glutamate released by U373 epilepsy model cells induced by magnesium-free cell culture medium, and the drug intervention model group was glutamate released by U373 epilepsy cell model cells after being treated with anti-epileptic drug lamotrigine solution; the results showed that the U373 epilepsy model cells induced by magnesium-free cell culture medium released more glutamate than normal U373 cells, indicating that the epilepsy model was successfully constructed; the glutamate released by U373 epilepsy model cells after being treated with lamotrigine solution was less than that of the epilepsy model group not treated with lamotrigine solution, indicating that lamotrigine can inhibit the release of glutamate by U373 epilepsy model cells; the above results all prove that microfluidic-electrochemical biosensors can be used for the detection of epilepsy-related non-electroactive neurotransmitter glutamate.
[0036] Advantages of the present invention: The present invention proposes a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter. The present invention realizes repeated detection of glutamate through a neurotransmitter affinity interface and peristaltic pump-driven cleaning. The electrochemical biosensor has good sensitivity and specificity. The laser cutting technology is used to realize low-cost large-scale preparation of microfluidic device substrates. The microfluidic device can be designed and assembled by simple splicing and bonding. At the same time, the microfluidic device is coupled with the electrochemical biosensor to realize continuous detection of glutamate in a variety of flowing liquids. It is successfully used for the determination of glutamate released by cells in epilepsy cell model groups and drug intervention model groups. The microfluidic-electrochemical biosensor provides scientific and technological support for the study of monitoring methods for epilepsy-related non-electroactive neurotransmitters such as glutamate, and can be used in the fields of microfluidic chip systems, epilepsy disease mechanisms and long-term monitoring research, organoid chip drug screening platforms, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 The present invention is a schematic diagram of the preparation and detection of a microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate.
[0038] Figure 2 Scanning electron microscope (SEM) characterization images of SPCE, CS / SPCE, and GLDH / GEL / CS / SPCE. Figure 2 A in the figure shows that the SPCE surface displays a large number of aggregated carbon particles and flake structures of different sizes. Figure 2 Figure B shows that after chitosan was modified onto SPCE, spherical aggregates were formed on the electrode surface. Figure 2 Middle C shows that after glutamate dehydrogenase and gelatin were mixed to modify the electrode interface, the interface became flat and a large number of bright spots appeared.
[0039] Figure 3 Electrochemical impedance spectra (EIS) of SPCE, CS / SPCE, and GLDH / GEL / CS / SPCE. Figure 3 After the surface of SPCE was modified with chitosan, its impedance value decreased from 1.25 kΩ (curve a) to 0.75 kΩ (curve b). This is because the positively charged chitosan and the negatively charged Fe(CN) 6 3- / Fe(CN) 6 4- Mutual attraction enhances the efficiency of electron transfer; after gelatin and glutamate dehydrogenase are modified to the CS / SPCE interface, the impedance value increases to 1.5kΩ (curve c), which is due to the non-conductivity of substances such as glutamate dehydrogenase and gelatin, which hinders electron transfer.
[0040] Figure 4Cyclic voltammetry (CV) spectra of the microfluidic-electrochemical biosensor in control solution, NADH solution and 500 μmol / L glutamate solution. Figure 4 Figure A shows that the control solution is 0.1 mol / LPB solution, and the CV curve of the 500 μmol / L NADH group shows an obvious oxidation peak at 0.55V. Figure 4 B is the control solution with 15mmol / L NAD + The CV curve of the 500 μmol / L glutamate (Glu) group showed an obvious oxidation peak at 0.66 V. Glutamate dehydrogenase catalyzes the reduction of glutamate to NAD + NADH is generated, and the NADH concentration is detected by electrochemical signals, thereby reflecting the glutamate concentration in the test solution. After the glutamate dehydrogenase is modified, the oxidation peak potential of the electrocatalytic reaction of NADH at the modified electrode interface shifts positively.
[0041] Figure 5 The CV spectra of 500 μmol / L glutamate at different scan rates in static and mobile systems, and the corresponding relationship between peak potential and scan rate. Figure 5 Figure A shows the electrocatalytic properties of the GLDH / GEL / CS / SPCE sensor for 500 μmol / L glutamate studied by CV method at different scan rates in a static system. The oxidation peak current value on the modified electrode increased significantly with the increase of the scan rate. Figure 5 Figure B shows the electrocatalytic properties of the sensor to 500 μmol / L glutamate were studied by CV method at different scan rates in a flow system. The variation trend of the oxidation peak current value with the scan rate is similar to that in the static state. Figure 5 C is Figure 5 A and Figure 5 The summary and fitting of different scan rates of B and CV peak current showed that the scan rate of both static and dynamic systems was linearly related to the current, indicating that glutamate was an irreversible process controlled by adsorption at the GLDH / GEL / CS / SPCE interface in both static and flow systems.
[0042] Figure 6 The specificity test results of the microfluidic-electrochemical biosensor for different interferents and glutamate. The specificity investigation result of the microfluidic-electrochemical biosensor shows that the current response signal generated by the microfluidic-electrochemical biosensor in 500μmol / L cysteine (Cys), phenylalanine (Phe), alanine (Ala), aspartic acid (Asp), serine (Ser), ascorbic acid (AA) and uric acid (UA) is negligible compared with the detection of glutamate (Glu) response current signal. This result shows that the microfluidic-electrochemical biosensor of the present invention has good specificity.
[0043] Figure 7 The DPV response current value result diagram of the microfluidic-electrochemical biosensor for five consecutive repeated detections of 500 μmol / L glutamate according to the operating steps, RSD = 4.28%. The results show that the microfluidic-electrochemical biosensor of the present invention can be used for multiple continuous detections of glutamate.
[0044] Figure 8 This is the response current-concentration relationship diagram of the microfluidic-electrochemical biosensor detecting different concentrations of glutamate in PB buffer. Figure 8 The DPV response current showed a good linear relationship with the glutamate concentration in the range of 0.1 μmol / L to 100 μmol / L, and the linear equation was I(nA)=3.32C Glu (μmol / L) + 83.2. The results show that the microfluidic-electrochemical biosensor of the present invention is suitable for the detection of glutamate in PB solution.
[0045] Fig. 9 This is the relationship between the response current and concentration of the microfluidic-electrochemical biosensor for detecting different concentrations of glutamate in DMEM / F12 complete culture medium. Fig. 9 The DPV response current showed a good linear relationship with the glutamate concentration in the range of 0.5 μmol / L to 100 μmol / L, and the linear equation was I(nA)=3.24C Glu (μmol / L)+45.7, and the detection limit is 155nmol / L. This result shows that the microfluidic-electrochemical biosensor of the present invention is suitable for glutamate detection in complete culture medium.
[0046] Fig.10 This is the response current-concentration relationship ratio diagram of the microfluidic-electrochemical biosensor in the static and flow systems to detect different concentrations of glutamate in the U373 cell contact solution. Fig.10 The DPV response current signal of the microfluidic-electrochemical biosensor for detecting glutamate in both static and dynamic systems showed a good linear relationship with the concentration in the range of 0.5μmol / L to 100μmol / L. The linear equation of the static system was I(nA)=1.59C Glu (μmol / L)+39.4, the linear equation of the dynamic system is I(nA)=2.16C Glu (μmol / L) + 173. This result indicates that the microfluidic-electrochemical biosensor of the present invention is suitable for detecting glutamate in U373 cell contact fluid.
[0047] Fig.11 Schematic diagram of the functions and assembly of each functional area of the microfluidic device. Fig.11 A in the middle is a schematic diagram of the cover plate and the flow slot. Fig.11 B is a schematic diagram of the device assembly. Fig.11 From left to right in A, there are the inlet for the test solution, the inlet for the buffer solution, the mixing area, the bubble collection area, the electrochemical detection area and the waste liquid outlet. The mixing unit designed in the flow channel of the mixing area is used to detect the NAD in the buffer solution. + Mix with the test liquid; a small circular area is designed between the mixing area and the electrochemical detection area to collect the gas flowing into the device from the peristaltic pump during the detection process to prevent the gas from entering the electrochemical detection area and interfering with the detection results; the electrochemical detection area is coupled with GLDH / GEL / CS / SPCE for glutamate detection flowing through the test liquid; the waste liquid outlet is used for the outflow of the test liquid.
[0048] Fig.12 This is a physical picture of the microfluidic-electrochemical biosensor.
[0049] Fig.13 The microfluidic-electrochemical biosensor monitors the response signal results of different concentrations of glutamate in a flow system. Fig.13 The time interval of continuous detection is 20min, and the microfluidic-electrochemical biosensor is cleaned after each measurement and then detected again. The corresponding glutamate concentrations of an are 0.5, 1, 5, 10, 50, 100, 500, 500, 100, 50, 10, 5, 1, and 0.5 μmol / L, respectively. The results show that the response current signal gradually increases with the increase of glutamate concentration, and the detection current values of glutamate at the same concentration are similar, indicating that the microfluidic-electrochemical biosensor of the present invention can be used for multiple, stable and continuous monitoring of glutamate.
[0050] Fig.14 The results of the microfluidic-electrochemical biosensor for the detection of glutamate release by stimulation of nerve cells. Human astroglioma cells (U373 cells) were used as model cells, and DMEM / F12 complete medium containing 100mmol / L KCl was used to stimulate the cells to release glutamate, and the microfluidic-electrochemical biosensor was used for detection. The control group was the glutamate released by normal U373 cells, the epilepsy model group was the glutamate released by U373 epilepsy model cells induced by magnesium-free cell culture medium, and the drug intervention group was the glutamate released by U373 epilepsy model cells after the action of anti-epileptic drug lamotrigine solution. The results showed that the U373 epilepsy model cells induced by magnesium-free cell culture medium released more glutamate than normal U373 cells, indicating that the epilepsy model was successfully constructed; the U373 epilepsy model cells after the action of lamotrigine solution released less glutamate than the epilepsy model group not acted with lamotrigine solution, indicating that lamotrigine can inhibit the release of glutamate from U373 epilepsy model cells. The above results were all obtained by detecting the microfluidic-electrochemical biosensor of the present invention, indicating that the microfluidic-electrochemical biosensor of the present invention can be used for the study of glutamate release from epileptic cells. DETAILED DESCRIPTION
[0051] In order to make the technical problem, technical solution and effect to be solved by the present invention clearer, the present invention is further described in detail below in conjunction with embodiments and drawings.
[0052] The operation steps of the microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, described in the present invention are as follows:
[0053] (1) Preparation of testing instruments, reagents and solutions;
[0054] The instruments and equipment used in this invention were purchased from the following companies:
[0055]
[0056] The reagents used in this invention are from the following companies:
[0057]
[0058]
[0059] All reagents were prepared according to the following formula:
[0060] ①0.1mol / L phosphate buffer (PB): accurately weigh 2.9642g NaH 2 PO 4 ·2H 2 O and 11.4988 g Na 2 HPO 4 Dissolve in 1000 mL ultrapure water, adjust pH to 7.4 with NaOH solution, and store at 4°C.
[0061] ②5mmol / LK 3 [Fe(CN) 6 ] / K 4 [Fe(CN) 6 ]Solution: Accurately weigh 0.4116 g K 3 [Fe(CN) 6 ]、0.5280gK 4 [Fe(CN) 6 ] and 1.8638 g KCl and dissolved in 250 mL 0.1 mol / LPB. 3 PO 4 Adjust pH to 7.0 and store at 4°C.
[0062] ③10mmol / L glutamic acid solution: Accurately weigh 0.0147g glutamic acid and dissolve it in 10mL 0.1mol / L PB. Store at 4℃ in the dark. Dilute it to the required concentration with 0.1mol / LPB before use.
[0063] ④10mmol / L NADH solution: Accurately weigh 0.0709g NADH and dissolve it in 10mL 0.1mol / L PB. Store at 4℃ in the dark and dilute it to the required concentration with 0.1mol / LPB before use.
[0064] ⑤20mmol / LNAD + Solution: Accurately weigh 0.1327 g NAD + Dissolve in 10mL 0.1mol / L PB, store at 4℃ away from light, and dilute to the required concentration with 0.1mol / L PB before use.
[0065] ⑥0.1 mol / L hydrochloric acid solution: dilute 0.4 mL of HCl in 47.6 mL of ultrapure water.
[0066] ⑦20 mg / mL chitosan (CS) solution: Accurately weigh 0.2000 g chitosan and dissolve it in 10 mL 0.1 mol / L hydrochloric acid solution. Store at 4 °C in the dark and dilute it to the required concentration with 0.1 mol / L hydrochloric acid solution before use.
[0067] ⑧10 mg / mL gelatin (GEL) solution: Accurately weigh 0.1000 g of gelatin and dissolve it in 10 mL of ultrapure water. Store at 4°C away from light and dilute with ultrapure water to the required concentration before use.
[0068] ⑨600U / mL glutamate dehydrogenase (GLDH) solution: Accurately weigh 0.0400g GLDH in PB, store at -20℃, and dilute to the required concentration with PB buffer before use.
[0069] ⑩ Magnesium-free cell culture medium: Accurately weigh 2.1185 g NaCl, 0.0466 g KCl, 0.0735 g CaCl2, 0.4504 g glucose, and 0.0188 g glycine and dissolve them in 247.5 mL ultrapure water. Add 2.5 mL HEPES buffer and mix well. Store at 4°C away from light.
[0070] DMEM / F12 complete medium: Add 50 mL of Australian fetal bovine serum and 5 mL of penicillin-streptomycin to 445 mL of DMEM / F12 culture medium to prepare DMEM / F12 complete medium and store at 4°C.
[0071] 100 μg / mL lamotrigine solution: Accurately weigh 0.005 g of lamotrigine and dissolve it in DMEM / F12 complete medium.
[0072] (2) Screen printed electrode (SPCE) cleaning: After cleaning the SPCE three times with ultrapure water, blow dry with nitrogen to obtain a cleaned SPCE for standby use;
[0073] (3) Preparation of chitosan-modified screen-printed electrode (CS / SPCE): 7 μL of 0.5 wt% chitosan solution was dripped onto the surface of the SPCE cleaned in step (1), and the mixture was dried naturally at room temperature to obtain a chitosan-modified screen-printed electrode (CS / SPCE);
[0074] (4) Preparation of glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode (GLDH / GEL / CS / SPCE): 5 μL of 400 U / mL glutamate dehydrogenase (GLDH) solution and 5 μL of 20 mg / mL gelatin (GEL) solution were mixed, and then added dropwise to the surface of CS / SPCE prepared in step (2), and incubated in a refrigerator at 4°C overnight to prepare glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode (GLDH / GEL / CS / SPCE);
[0075] (5) Preparation of microfluidic device substrate: Use WPS Office PowerPoint to draw the plane structure of the cover plate and the flow slot of the microfluidic substrate. The flow slot is 5.2 cm long, 2 cm wide, and 0.1 cm thick. It includes the test liquid inlet, buffer inlet, cleaning liquid inlet, mixing area, bubble collection area, electrochemical detection area, and waste liquid outlet. The overall size (length and width) and thickness of the cover are exactly the same as those of the flow slot, including the test liquid inlet, buffer inlet, cleaning liquid inlet, bubble collection area, and waste liquid outlet. According to the pattern drawn on the substrate, a laser engraving machine is used to carve out a hollow part on the acrylic plate to make the cover plate and the flow slot. The detection area is a hollow circle with a radius of 0.5 cm, which is slightly larger than the SPCE working area, and the microfluidic device substrate is obtained.
[0076] (6) Preparation of microfluidic-electrochemical biosensor: The top surface of the flow channel sheet of the microfluidic device substrate obtained in step (5) was adhered with a 0.2 mm thick PET transparent double-sided tape, and the double-sided tape at the liquid inlet and outlet was hollowed out, and the top surface was adhered to the cover plate, and the GLDH / GEL / CS / SPCE obtained in step (4) was adhered to the detection area of the flow channel sheet, with the GLDH / GEL / CS / SPCE modified interface facing the flow channel sheet, and the bottom surface was sealed with a 2 mm thick flexible strong tape, and the gap was filled with photocurable resin, and photocured under LED light for 120 seconds to obtain a microfluidic-electrochemical biosensor.
[0077] (7) Connecting the microfluidic-electrochemical biosensor to a peristaltic pump: A rubber hose is connected to each of the sample inlets and waste liquid outlets of the microfluidic-electrochemical biosensor prepared in step (6), the other end of the rubber hose of the sample inlet is connected to a peristaltic pump, and the other end of the rubber hose of the waste liquid outlet is placed in a waste liquid collection tank.
[0078] (8) Electrochemical detection of microfluidic-electrochemical biosensor during liquid circulation: A peristaltic pump was used to mix the glutamate test solution with NAD at a flow rate of 5 μL / min. + The buffer solution was pumped into the microfluidic-electrochemical biosensor from the test solution and the buffer injection port, respectively, and mixed using the microchannel to fill the detection area and remain there for 10 minutes. During this period, glutamate dehydrogenase catalyzed the reduction of glutamate to NAD + Generate NADH. Using CHI660E electrochemical workstation, differential pulse voltammetry (DPV) was used to detect the neurotransmitter glutamate, with a detection potential of 0-0.8V, an amplitude of 0.05V, a pulse width of 0.1s, a pulse period of 0.2s, and the oxidation peak current value was recorded.
[0079] (9) Cleaning of the microfluidic-electrochemical biosensor: After the electrochemical detection of the neurotransmitter glutamate in step (8) is completed, the pumping of the solution in the test solution inlet and the buffer inlet is stopped, and the peristaltic pump of the cleaning solution inlet is started to pump the PB buffer into the microfluidic-electrochemical biosensor through the cleaning solution inlet at a flow rate of 50 μL / min to clean the test area. After cleaning, the pumping of the PB buffer is stopped, and step (8) is repeated to perform the neurotransmitter glutamate detection.
[0080] (10) Application of microfluidic-electrochemical biosensors to detect the level of glutamate released by cells in epilepsy cell models: Human astroglioma cells (U373 cells) were used as model cells to construct an epilepsy model. DMEM / F12 complete culture medium containing 100 mmol / L KCl was used to stimulate the cells to release the neurotransmitter glutamate, and the microfluidic-electrochemical biosensor was used to detect the level of glutamate released by the cells. The control group was glutamate released by normal U373 cells, the epilepsy model group was glutamate released by U373 epilepsy model cells induced by magnesium-free cell culture medium, and the drug intervention group was glutamate released by U373 epilepsy model cells after being treated with anti-epileptic drug lamotrigine solution. The results showed that the U373 epilepsy model cells induced by magnesium-free cell culture medium released more glutamate than normal U373 cells, indicating that the epilepsy model was successfully constructed; the U373 epilepsy model cells after the action of lamotrigine solution released less glutamate than the epilepsy model group not acted with lamotrigine solution, indicating that lamotrigine can inhibit the release of glutamate from U373 epilepsy model cells. The above results all prove that the microfluidic-electrochemical biosensor of the present invention can be used for the detection of glutamate, a non-electroactive neurotransmitter related to epilepsy.
[0081] The microfluidic-electrochemical biosensor prepared in the present invention is shown in 1. Figure 1 The present invention is a schematic diagram of the preparation and detection of a microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate.
[0082] Figure 2 Scanning electron microscope (SEM) characterization pictures of SPCE, CS / SPCE and GLDH / GEL / CS / SPCE of the present invention. Figure 2 A in the figure shows that the SPCE surface displays a large number of aggregated carbon particles and flake structures of different sizes. Figure 2 Figure B shows that after chitosan was modified onto SPCE, spherical aggregates were formed on the electrode surface. Figure 2 Middle C shows that after glutamate dehydrogenase and gelatin were mixed to modify the electrode interface, the interface became flat and a large number of bright spots appeared.
[0083] Figure 3 These are the electrochemical impedance spectra (EIS) of SPCE, CS / SPCE, and GLDH / GEL / CS / SPCE of the present invention. Figure 3 After the surface of SPCE was modified with chitosan, its impedance value decreased from 1.25 kΩ (curve a) to 0.75 kΩ (curve b). This is because the positively charged chitosan and the negatively charged Fe(CN) 6 3- / Fe(CN) 6 4-affinity, enhancing the efficiency of electron transfer; after gelatin and glutamate dehydrogenase were modified to the CS / SPCE interface, the impedance value increased to 1.5kΩ (curve c), which is due to the non-conductivity of substances such as glutamate dehydrogenase and gelatin, which hinders electron transfer.
[0084] Figure 4 The cyclic voltammetry (CV) spectra of the microfluidic-electrochemical biosensor of the present invention in a control solution, a NADH solution and a 500 μmol / L glutamic acid solution. Figure 4 Figure A shows that the control solution is 0.1 mol / L PB solution, and the CV curve of the 500 μmol / L NADH group shows an obvious oxidation peak at 0.55 V. Figure 4 B is the control solution with 15mmol / L NAD + The CV curve of the 500 μmol / L glutamate group showed an obvious oxidation peak at 0.66 V, and the peak current value increased with the increase of glutamate concentration. Glutamate dehydrogenase catalyzes the reduction of glutamate to NAD + NADH is generated, and the NADH concentration is detected by electrochemical signals, thereby reflecting the glutamate concentration in the test solution. After the glutamate dehydrogenase is modified, the oxidation peak potential of the electrocatalytic reaction of NADH at the modified electrode interface shifts positively.
[0085] Figure 5 The CV spectra of 500 μmol / L glutamic acid at different scanning rates in static and flowing systems of the present invention, and the relationship diagram between the corresponding peak potential and the scanning rate. Figure 5 Figure A shows the electrocatalytic properties of the GLDH / GEL / CS / SPCE sensor to 500 μmol / L glutamate studied by CV method at different scan rates in a static system. Figure 5 Figure B shows the electrocatalytic properties of the sensor to 500 μmol / L glutamate were studied by CV method at different scan rates in a flow system. The variation trend of the oxidation peak current value with the scan rate is similar to that in the static state. Figure 5 C is Figure 5 A and Figure 5 The summary and fitting of different scan rates of B and CV peak current showed that the scan rate and current of static and dynamic systems were linearly related, indicating that glutamate was an irreversible process controlled by adsorption at the GLDH / GEL / CS / SPCE interface in both static and flow systems.
[0086] Figure 6The specificity test results of the microfluidic-electrochemical biosensor of the present invention for different interferents and glutamate. The specificity investigation result of the microfluidic-electrochemical biosensor shows that the current response signal generated by the microfluidic-electrochemical biosensor in 500μmol / L cysteine (Cys), phenylalanine (Phe), alanine (Ala), aspartic acid (Asp), serine (Ser), ascorbic acid (AA) and uric acid (UA) is negligible compared with the detection of glutamate (Glu) response current signal. This result shows that the microfluidic-electrochemical biosensor of the present invention has good specificity.
[0087] Figure 7 The DPV response current value result diagram of the microfluidic-electrochemical biosensor of the present invention for five consecutive repeated detections of 500 μmol / L glutamate according to the operating steps, RSD = 4.28%. The results show that the microfluidic-electrochemical biosensor of the present invention can be used for multiple continuous detections of glutamate.
[0088] Figure 8 The graph is a response current-concentration relationship diagram of the microfluidic-electrochemical biosensor of the present invention to detect different concentrations of glutamate in PB buffer. Figure 8 The DPV response current showed a good linear relationship with the glutamate concentration in the range of 0.1 μmol / L to 100 μmol / L, and the linear equation was I(nA)=3.32C Glu (μmol / L) + 83.2. This result indicates that the microfluidic-electrochemical biosensor of the present invention is suitable for the detection of glutamate in PB solution.
[0089] Fig. 9 The graph is a relationship between the response current and the concentration of the microfluidic-electrochemical biosensor of the present invention when detecting different concentrations of glutamate in DMEM / F12 complete culture medium. Fig. 9 The DPV response current showed a good linear relationship with the glutamate concentration in the range of 0.5 μmol / L to 100 μmol / L, and the linear equation was I(nA)=3.24C Glu (μmol / L)+45.7, and the detection limit is 155nmol / L. This result shows that the microfluidic-electrochemical biosensor of the present invention is suitable for glutamate detection in complete culture medium.
[0090] Fig.10 The graph is a response current-concentration relationship ratio diagram of the microfluidic-electrochemical biosensor of the present invention under static and flow systems to detect different concentrations of glutamate in U373 cell contact fluid. Fig.10The DPV response current signal of the microfluidic-electrochemical biosensor for detecting glutamate in both static and dynamic systems showed a good linear relationship with the concentration in the range of 0.5μmol / L to 100μmol / L. The linear equation of the static system was I(nA)=1.59C Glu (μmol / L)+39.4, the linear equation of the dynamic system is I(nA)=2.16C Glu (μmol / L) + 173. This result indicates that the microfluidic-electrochemical biosensor of the present invention is suitable for detecting glutamate in U373 cell contact fluid.
[0091] Fig.11 Schematic diagram of the functions and assembly of each functional area of the microfluidic device of the present invention. Fig.11 A in the middle is a schematic diagram of the cover plate and the flow slot. Fig.11 B is a schematic diagram of the device assembly. Fig.11 From left to right in A, there are the inlet for the test solution, the inlet for the buffer solution, the mixing area, the bubble collection area, the electrochemical detection area and the waste liquid outlet. The mixing unit designed in the flow channel of the mixing area is used to detect the NAD in the buffer solution. + Mix with the test liquid; a small circular area is designed between the mixing area and the electrochemical detection area to collect the gas flowing into the device from the peristaltic pump during the detection process to prevent the gas from entering the electrochemical detection area and interfering with the detection results; the electrochemical detection area is coupled with GLDH / GEL / CS / SPCE for glutamate detection flowing through the test liquid; the waste liquid outlet is used for the outflow of the test liquid.
[0092] Fig.12 This is a physical picture of the microfluidic-electrochemical biosensor of the present invention.
[0093] Fig.13 The microfluidic-electrochemical biosensor of the present invention monitors the response signal results of glutamate of different concentrations in a flow system. Fig.13 The time interval of continuous detection is 20min, and the microfluidic-electrochemical biosensor is cleaned after each measurement and then detected again. The corresponding glutamate concentrations of an are 0.5, 1, 5, 10, 50, 100, 500, 500, 100, 50, 10, 5, 1, and 0.5 μmol / L, respectively. The results show that the response current signal gradually increases with the increase of glutamate concentration, and the detection current values of glutamate at the same concentration are similar, indicating that the microfluidic-electrochemical biosensor of the present invention can be used for multiple, stable and continuous monitoring of glutamate.
[0094] Fig.14The present invention is a microfluidic-electrochemical biosensor for the detection result of glutamate release by nerve cell stimulation. Human astroglioma cells (U373 cells) were used as model cells, and DMEM / F12 complete medium containing 100mmol / L KCl was used to stimulate cells to release glutamate, and microfluidic-electrochemical biosensor was used for detection. The control group was glutamate released by normal U373 cells, the epilepsy model group was glutamate released by U373 epilepsy model cells induced by magnesium-free cell culture fluid, and the drug intervention group was glutamate released by U373 epilepsy model cells after the action of anti-epileptic drug lamotrigine solution. The results show that the glutamate released by the U373 epilepsy model cells induced by magnesium-free cell culture fluid is more than that of normal U373 cells, indicating that the epilepsy model was successfully constructed; the glutamate released by the U373 epilepsy model cells after the action of lamotrigine solution is less than that of the epilepsy model group without the action of lamotrigine solution, indicating that lamotrigine can inhibit the release of glutamate by U373 epilepsy model cells. The above results were all obtained by detecting the microfluidic-electrochemical biosensor of the present invention, indicating that the microfluidic-electrochemical biosensor of the present invention can be used for the study of glutamate release from epileptic cells.
Claims
1. A microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate, It is characterized in that The method is prepared by the following steps: (1) fixing glutamate dehydrogenase on the surface of a screen-printed electrode by cross-linking chitosan and gelatin to obtain a glutamate dehydrogenase-modified screen-printed electrode; (2) using acrylic material to prepare a microfluidic device substrate by precise engraving technology; (3) assembling the glutamate dehydrogenase-modified screen-printed electrode prepared in step (1) with the microfluidic device substrate prepared in step (2) to prepare a microfluidic-electrochemical biosensor; (4) using the prepared microfluidic-electrochemical biosensor to detect the glutamate content in a flowing liquid sample by differential pulse voltammetry; (5) driving the liquid flow by a peristaltic pump to transport the test liquid and buffer solution to detect glutamate and clean the microfluidic-electrochemical biosensor electrode.
2. A microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, as claimed in claim 1, It is characterized in that Applicable test solutions include phosphate buffer containing glutamate or U373 cell contact solution. The glutamate concentration in the phosphate buffer ranges from 0.1 μmol / L to 100 μmol / L, and the glutamate concentration in the U373 cell contact solution ranges from 0.5 μmol / L to 100 μmol / L.
3. A microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, as claimed in claim 1 or 2, It is characterized in that The entire process of liquid flow, signal detection and electrode cleaning in the microfluidic-electrochemical biosensor is completely controlled by a peristaltic pump and an electrochemical workstation, which can stably and continuously monitor the glutamate content in the test solution.
4. A method for preparing a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, comprising the following steps in sequence: (1) After the surface of the screen-printed electrode SPCE is cleaned, chitosan CS is modified on the surface of the screen-printed electrode to prepare chitosan-modified screen-printed electrode CS / SPCE; (2) Further modifying the surface of CS / SPCE with gelatin GEL and glutamate dehydrogenase GLDH to prepare glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode GLDH / GEL / CS / SPCE; (3) Design and manufacture microfluidic device substrates, assemble GLDH / GEL / CS / SPCE with the microfluidic device substrate to make a microfluidic-electrochemical biosensor; (4) Detection of the neurotransmitter glutamate in flowing liquid using microfluidic-electrochemical biosensors; (5) After the neurotransmitter glutamate is detected, the electrode surface of the microfluidic-electrochemical biosensor is cleaned with phosphate buffer driven by a peristaltic pump. After cleaning, step (4) of detecting the neurotransmitter glutamate is repeated.
5. The detection operation method of the microfluidic-electrochemical biosensor prepared by the preparation method of the microfluidic-electrochemical biosensor for continuous monitoring of the epilepsy-related non-electroactive neurotransmitter glutamate as claimed in claim 4, characterized in that it comprises the following specific steps: (1) Cleaning of screen-printed electrode SPCE: After cleaning the SPCE with ultrapure water for 3 times, blow dry with nitrogen to obtain the cleaned SPCE for later use; (2) Preparation of chitosan-modified screen-printed electrode CS / SPCE: 7 μL of 0.5 wt% chitosan solution was dripped onto the surface of SPCE cleaned in step (1), and the mixture was dried naturally at room temperature to obtain chitosan-modified screen-printed electrode CS / SPCE. (3) Preparation of glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode GLDH / GEL / CS / SPCE: Mix 5 μL of 400 U / mL glutamate dehydrogenase GLDH solution and 5 μL of 20 mg / mL gelatin GEL solution, and then drop them on the surface of CS / SPCE prepared in step (2), and incubate them in a refrigerator at 4 °C overnight to prepare glutamate dehydrogenase, gelatin and chitosan modified screen-printed electrode GLDH / GEL / CS / SPCE; (4) Preparation of microfluidic device substrate: Use WPS Office PowerPoint to draw the planar structure of the cover plate and the flow slot of the microfluidic substrate. The flow slot is 5.2 cm long, 2 cm wide and 0.1 cm thick. The flow slot includes a sample inlet for the test liquid, a buffer inlet, a cleaning liquid inlet, a mixing area, a bubble collection area, an electrochemical detection area and a waste liquid outlet. The overall length, width and thickness of the cover are completely consistent with those of the flow slot. The cover includes a sample inlet for the test liquid, a buffer inlet, a cleaning liquid inlet, a bubble collection area and a waste liquid outlet. According to the pattern drawn on the substrate, a laser engraving machine is used to carve out a hollow part on the acrylic plate to make the cover plate and the flow slot. The detection area is a hollow circle with a radius of 0.5 cm, which is slightly larger than the SPCE working area, to obtain the microfluidic device substrate. (5) Preparation of microfluidic-electrochemical biosensor: The top surface of the flow channel sheet of the microfluidic device substrate prepared in step (4) is adhered with a 0.2 mm thick PET transparent double-sided tape, and the double-sided tape at the liquid inlet and outlet is hollowed out, and the top surface is adhered to the cover plate, and the GLDH / GEL / CS / SPCE prepared in step (3) is adhered to the detection area of the flow channel sheet, with the GLDH / GEL / CS / SPCE modified interface facing the flow channel sheet, and the bottom surface is sealed with a 2 mm thick flexible strong tape, and the gap is filled with light-curable resin, and light-cured for 120 s under LED light to prepare a microfluidic-electrochemical biosensor; (6) Connecting the microfluidic-electrochemical biosensor to a peristaltic pump: Connect a rubber hose to each of the sample inlets and waste liquid outlets of the microfluidic-electrochemical biosensor prepared in step (5), the other end of the rubber hose of the sample inlet is connected to a peristaltic pump, and the other end of the rubber hose of the waste liquid outlet is placed in a waste liquid collection tank; (7) Electrochemical detection of microfluidic-electrochemical biosensor during liquid flow: A peristaltic pump was used to mix the glutamate test solution with NAD at a flow rate of 5 μL / min. + The buffer solution was pumped into the microfluidic-electrochemical biosensor from the test solution and the buffer injection port, respectively, and mixed using the microchannel to fill the detection area and remain there for 10 min. During this period, glutamate dehydrogenase catalyzed the reduction of glutamate to NAD + NADH was generated, and the neurotransmitter glutamate was detected by differential pulse voltammetry (DPV) using a CHI660E electrochemical workstation. The detection potential was 0-0.8 V, the amplitude was 0.05 V, the pulse width was 0.1 s, the pulse period was 0.2 s, and the oxidation peak current value was recorded. (8) Cleaning of the microfluidic-electrochemical biosensor: After the electrochemical detection of the neurotransmitter glutamate in step (7) is completed, stop pumping the solution into the test solution inlet and the buffer inlet, start the peristaltic pump of the cleaning solution inlet, and pump phosphate buffer PB into the microfluidic-electrochemical biosensor through the cleaning solution inlet at a flow rate of 50 μL / min to clean the test area. After cleaning, stop pumping the PB buffer and repeat step (7) to perform neurotransmitter glutamate detection.
6. Application of the microfluidic-electrochemical biosensor prepared by the preparation method of a microfluidic-electrochemical biosensor for continuous monitoring of glutamate, an epilepsy-related non-electroactive neurotransmitter, as claimed in claim 4, Features: The glutamate released by cells in the epilepsy cell model group, control model group and drug intervention model group was measured; human astroglioma cells (U373 cells) were used as model cells to construct an epilepsy model, and 100 mmol / L KCl-free DMEM / F12 complete medium stimulated cells to release the neurotransmitter glutamate, and the level of glutamate released by cells was detected using microfluidic-electrochemical biosensor; the control model group was glutamate released by normal U373 cells, the epilepsy cell model group was glutamate released by U373 epilepsy model cells induced by magnesium-free cell culture medium, and the drug intervention model group was glutamate released by U373 epilepsy cell model cells after being treated with anti-epileptic drug lamotrigine solution; the results showed that the U373 epilepsy model cells induced by magnesium-free cell culture medium released more glutamate than normal U373 cells, indicating that the epilepsy model was successfully constructed; the glutamate released by U373 epilepsy model cells after being treated with lamotrigine solution was less than that of the epilepsy model group not treated with lamotrigine solution, indicating that lamotrigine can inhibit the release of glutamate by U373 epilepsy model cells; the above results all prove that microfluidic-electrochemical biosensors can be used for the detection of epilepsy-related non-electroactive neurotransmitter glutamate.
Citation Information
Patent Citations
Preparation method of glutamic acid biosensor
CN111007125A
AuNPs (at) Cu-MOF / MWCNTs surface modification electrochemical sensor and preparation method and application thereof
CN117347445A
Sensor and real-time electrochemical detection device
CN219179287U
Device and methods of using device for detection of aminoacidopathies
US20160168613A1
Device and Method for Pre-Term Birth Risk Assessment
US20220296221A1
